Leukemia Clinical Trials

Showing 3441-3460 of 5,235 trials

A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases

NCT03193177

Effectiveness of fasting or fasting-mimicking diet has been proved an effective approach to treat metabolic and autoimmune diseases in mice. However, clinical trials performing prolonged fasting with more than 7 days have not been reported. Investigators conduct an open label, phase I/II clinical trial to evaluate the safety and effectiveness of the 21-day fasting-like diet in the treatment of metabolic and autoimmune diseases.

FastingChronic DiseaseAutoimmune Diseases+6 more

Tsinghua University144 participantsStarted Jun 2017

Longkou, Shandong, China

TERMINATEDPhase 1

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

NCT03672851

This is a single arm, open-label, phase 1 study, to determine the safety and efficacy of anti-CD123 CAR-T cells in treating patients diagnosed with refractory/relapsed acute leukemia in a dose-escalation way.

Acute LeukemiaAcute Leukemia in RelapseAcute Myeloid Leukemia+1 more

Second Affiliated Hospital of Xi'an Jiaotong University2 participantsStarted Apr 2019

Xi'an, Shaanxi, China

COMPLETED

Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula

NCT03769051

The main purpose of this study was to observe the effect of amino acid formula on infants with cow's milk protein allergy; to evaluate the role of food avoidance and Open Food Challenge test in the diagnosis of infants with cow's milk protein allergy; to observe the allergic process in infants with cow's milk protein allergy and to explore the criteria for diagnosis and treatment.

Cow's Milk Protein Allergy

Peking University Third Hospital200 participantsStarted Jun 2015

A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula

Related Searches

A Novel Biologic Therapy for Perennial Allergic Rhinitis

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC

Detection of Circulating Biomarkers of Immunogenic Cell Death

Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)

Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)